Ftse Mib
34.072,72
0,99%
DAX
19.958,63
0,61%
S&P 500
5.957,44
-1,33%
NASDAQ
19.682,74
-1,69%
Bitcoin
94.305,32
-1,45%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Jazz Pharmaceuticals PLC (JAZZ) Jazz Pharmaceuticals PLC (JAZZ) Notizie

Jazz Pharmaceuticals PLC

JAZZ
124,525
-1,30 (-1,03%)
Ultimo aggiornamento: 17:30:12
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202422:15PRNUSJazz Pharmaceuticals to Present at the 43rd Annual J.P...
16/12/202422:43EDGAR2Form 8-K - Current report
16/12/202422:05PRNUSJazz Pharmaceuticals Announces CEO Succession Plan
10/12/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:05PRNUSJazz Pharmaceuticals to Showcase New Real-World Evidence..
05/12/202413:45PRNUSJazz Pharmaceuticals Announces Update to National..
04/12/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:15PRNUSJazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii)..
03/12/202413:49PRNUSJazz Pharmaceuticals to Present Advancements in Solid Tumors..
02/12/202422:20EDGAR2Form 144 - Report of proposed sale of securities
21/11/202412:06EDGAR2Form 8-K - Current report
21/11/202401:19PRNUSJazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera®..
19/11/202422:05PRNUSJazz Pharmaceuticals to Participate in Citi's 2024 Global..
13/11/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202423:55EDGAR2Form 144 - Report of proposed sale of securities
07/11/202413:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:06EDGAR2Form 8-K - Current report
06/11/202422:05PRNUSJazz Pharmaceuticals Announces Third Quarter 2024 Financial..
31/10/202421:05PRNUSJazz Pharmaceuticals Presents New Data at Psych Congress..
23/10/202422:15PRNUSJazz Pharmaceuticals to Report 2024 Third Quarter Financial..
21/10/202422:11EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202422:13EDGAR2Form 8-K - Current report
15/10/202416:31PRNUSPharmaMar Announces Positive and Statistically Significant..
15/10/202413:30PRNUSJazz Pharmaceuticals Announces Statistically Significant..
16/9/202413:30PRNUSJazz Pharmaceuticals Presents Updated Phase 2 Data for..
11/9/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202413:58PRNUSJazz Pharmaceuticals to Present Advancements in Solid Tumor..
06/9/202422:09EDGAR2Form 8-K - Current report
06/9/202401:50EDGAR2Form 144 - Report of proposed sale of securities
05/9/202413:30PRNUSJazz Pharmaceuticals to Present New Data Demonstrating..
04/9/202406:12PRNUSJazz Pharmaceuticals Announces Pricing of Private Offering..
04/9/202406:00PRNUSJazz Pharmaceuticals Announces Pricing of Private Offering..
03/9/202413:00PRNUSJazz Pharmaceuticals Announces Private Offering of $850..
28/8/202420:27EDGAR2Form 8-K - Current report
22/8/202422:05PRNUSJazz Pharmaceuticals Provides Update on Cannabidiol Oral..
21/8/202422:15PRNUSJazz Pharmaceuticals to Participate in Upcoming September..
07/8/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202403:57EDGAR2Form 144 - Report of proposed sale of securities
06/8/202403:55EDGAR2Form 144 - Report of proposed sale of securities
06/8/202403:42EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 125,35 Min: 124,12 Max: 126,5028
Chiusura: 125,82

La tua Cronologia

NASDAQ
JAZZ
Jazz Pharmaceuticals
NASDAQ
ABNZAXX
Royal Bank of Canada Cap...
NASDAQ
CUE
Cue Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network